Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Treatment of bacteraemia: meticillin-resistant Staphylococcus aureus (MRSA) to vancomycin-resistant S. aureus (VRSA).

International journal of antimicrobial agents - 1 Jun 2013

Gould I M

Abstract excerpt

Around the world, Staphylococcus aureus remains a dominant cause of bacteraemia. Whilst meticillin resistance remains the major phenotype of concern, various levels of reduced glycopeptide susceptibility are emerging with increasing frequency. The most common MRSA phenotypes now have raised vancomycin MICs within the susceptible range (MICs of 1-2mg/L). This phenomenon, known as MIC creep, is hotly contested and...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Anti-Bacterial Agents
Share to Bacteremia
Share to Methicillin-Resistant Staphylococcus aureus

Methodology Data sources Editorial policy Privacy Delete account & data About Contact Helena Bioinformatics

Share to Microbial Sensitivity Tests

Share to Staphylococcal Infections

Share to Teicoplanin

Share to Vancomycin

Share to Vancomycin Resistance

Source

Identifiers

PMID: 23664580
DOI: 10.1016/j.ijantimicag.2013.04.006

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-08.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence. Graph snapshot: 2026-09-29.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Treatment of bacteraemia: meticillin-resistant Staphylococcus aureus (MRSA) to vancomycin-resistant S. aureus (VRSA).PMID 23664580Read ↗

The treatment of resistant staphylococcal infectionsSemantic proximity Read ↗

The association of molecular typing, vancomycin MIC, and clinical outcome for patients with methicillin-resistant Staphylococcus aureus infections.Semantic proximity Read ↗

Insights into the molecular basis of reduced vancomycin susceptibility among three prominent Staphylococcus aureus clonal complexesSemantic proximity Read ↗

Methicillin-resistant Staphylococcus aureus: related infections and antibiotic resistanceSemantic proximity Read ↗

Acquired Vancomycin Resistance in Clinically Relevant PathogensSemantic proximity Read ↗

The escalating challenge of vancomycin resistance in Staphylococcus aureus.Semantic proximity Read ↗

Reduced vancomycin susceptibility in Staphylococcus aureus clinical isolates: a spectrum of less investigated uncertaintiesSemantic proximity Read ↗

Genomic and phenotypic adaptations of methicillin resistant Staphylococcus aureus during vancomycin therapySemantic proximity Read ↗

The evolution of vancomycin intermediate Staphylococcus aureus (VISA) and heterogenous-VISA.Semantic proximity Read ↗

Mechanisms of vancomycin resistance in Staphylococcus aureus.Semantic proximity Read ↗

Staphylococcus aureus response and adaptation to vancomycin.Semantic proximity Read ↗

An induced mutation of ABC-transporter component VraF(K84E) contributes to vancomycin resistance and virulence in Staphylococcus aureus strain MW2.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.